• 1. Molecularly imprinted polymers’ application in pesticide residue detection
  Saqib Farooq,Jiyun Nie,Yang Cheng,Zhen Yan,Jing Li,Syed Asim Shah Bacha,Aamar Mushtaq,Hui Zhang Analyst 2018 143 3971

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Diphenylethers

Introduction to 3-(4'-Hydroxy)phenoxybenzoic Acid (CAS No. 35065-12-4)

3-(4'-Hydroxy)phenoxybenzoic acid, identified by the chemical compound identifier CAS No. 35065-12-4, is a significant molecule in the realm of pharmaceutical and biochemical research. This compound, featuring a benzoic acid core substituted with a phenoxy group at the C-3 position and a hydroxyl group at the C-4' position of the phenyl ring, has garnered attention due to its structural uniqueness and potential biological activities. The precise arrangement of functional groups in its molecular structure imparts distinct chemical properties, making it a valuable candidate for further exploration in drug discovery and therapeutic applications.

The molecular structure of 3-(4'-Hydroxy)phenoxybenzoic acid can be described as a derivative of benzoic acid, where the phenoxy group (-O-C?H?-) is attached to the third carbon atom of the benzoic acid backbone, and a hydroxyl group (-OH) is present on the fourth carbon atom of the attached phenyl ring. This configuration creates a molecule with both hydrophilic and lipophilic characteristics, which is often advantageous for membrane permeability and interaction with biological targets. The presence of two aromatic rings linked by oxygen atoms enhances its potential for π-π stacking interactions, a feature that is frequently exploited in drug design to improve binding affinity.

In recent years, 3-(4'-Hydroxy)phenoxybenzoic acid has been studied for its potential pharmacological effects. Research has indicated that this compound may exhibit antioxidant, anti-inflammatory, and antimicrobial properties. These attributes are particularly intriguing in the context of developing novel therapeutic agents for chronic diseases where oxidative stress and inflammation play critical roles. For instance, studies have suggested that the hydroxyl group in 3-(4'-Hydroxy)phenoxybenzoic acid could participate in redox reactions, potentially mitigating oxidative damage by scavenging reactive oxygen species (ROS).

The anti-inflammatory potential of 3-(4'-Hydroxy)phenoxybenzoic acid has also been explored, particularly in relation to modulating key inflammatory pathways such as NF-κB and MAPK. Preclinical studies have demonstrated that this compound may inhibit the production of pro-inflammatory cytokines like TNF-α, IL-1β, and IL-6 by interacting with specific enzymes involved in their synthesis. Such findings are promising for developing treatments targeting inflammatory conditions such as rheumatoid arthritis, inflammatory bowel disease, and even certain types of cancer where inflammation is a contributing factor.

Beyond its anti-inflammatory and antioxidant properties, 3-(4'-Hydroxy)phenoxybenzoic acid has shown promise in antimicrobial applications. The structural features of this compound allow it to disrupt bacterial cell membranes or interfere with essential metabolic pathways, leading to reduced bacterial growth. This makes it a candidate for developing new antibiotics or antimicrobial agents to combat drug-resistant bacteria. The growing crisis of antibiotic resistance underscores the need for innovative approaches to infection control, and compounds like 3-(4'-Hydroxy)phenoxybenzoic acid offer a ray of hope.

The synthesis of 3-(4'-Hydroxy)phenoxybenzoic acid involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include the coupling of phenoxyacetic acid derivatives with appropriate benzoic acid precursors under controlled conditions. Advances in synthetic methodologies have enabled more efficient production processes, making larger-scale synthesis feasible for research and commercial purposes.

From a computational chemistry perspective, 3-(4'-Hydroxy)phenoxybenzoic acid has been subjected to various modeling studies to understand its interactions with biological targets at the molecular level. Techniques such as molecular dynamics simulations (MD), quantum mechanics (QM), and docking studies have been employed to predict binding affinities and mechanisms of action. These computational approaches not only accelerate the drug discovery process but also provide insights into how modifications to the structure might enhance efficacy or reduce side effects.

The pharmacokinetic profile of 3-(4'-Hydroxy)phenoxybenzoic acid is another area of interest. Studies have investigated its absorption, distribution, metabolism, excretion (ADME), and toxicity (ADMET) properties to assess its suitability as a drug candidate. Understanding these parameters is crucial for determining appropriate dosing regimens and predicting potential adverse effects. For example, assessing metabolic stability helps in identifying whether the compound will be rapidly broken down in vivo or persist longer, influencing its therapeutic window.

In conclusion,3-(4'-Hydroxy)phenoxybenzoic acid (CAS No. 35065-12-4) represents a promising molecule with diverse biological activities that make it valuable for pharmaceutical research. Its unique structural features enable interactions with multiple biological pathways, offering potential benefits in treating inflammatory diseases, oxidative stress-related conditions, and infections. Continued research into its synthesis, pharmacological effects, and pharmacokinetic properties will further elucidate its therapeutic potential and guide future development efforts.

• 100-09-4(p-Anisic acid)
• 1132-21-4(3,5-Dimethoxybenzoic acid)
• 27914-54-1(4-Methoxy-d3-benzoic Acid)
• 21120-65-0(4-(4-Methylphenoxy)benzoic Acid)
• 621-51-2(3-Ethoxybenzoic acid)
• 3739-38-6(3-Phenoxybenzoic acid)
• 2215-77-2(4-Phenoxybenzoic acid)
• 586-38-9(3-Methoxybenzoic acid)
• 46331-50-4(5-Methoxyisophthalic acid)
• 2215-89-6(4,4'-Oxybis(benzoic Acid))